Abstract
AbstractNew technologies create new complexities. Since non-invasive prenatal tests (NIPTs) were first introduced, keeping pace with complexity constitutes an ongoing task for medical societies, politics, and practice. NIPTs analyse the chromosomes of the fetus from a small blood sample. Initially, NIPTs were targeted at detecting trisomy 21 (Down syndrome): meanwhile there are sequencing techniques capable of analysing the entire genome of the unborn child. These yield findings of unclear relevance for the child’s future life, resulting in new responsibility structures and dilemmas for the parents-to-be.The industry’s marketing strategies overemphasize the benefits of the tests while disregarding their consequences. This paper chooses the opposite path: starting with the underestimated consequences, it focuses on adverse developments and downsides. Disparities, paradoxes, and risks associated with NIPTs are illustrated, ethical conflicts described. Indications that new technologies developed to solve problems create new ones are examined. In the sense of critical thinking, seemingly robust knowledge is scrutinized for uncertainties and ambiguities. It analyses how the interplay between genetic knowledge and social discourse results in new dimensions of responsibility not only for parents-to-be, but also for decision-makers, authorities, and professional societies, illustrated by a review of different national policies and implementation programmes. As shown by the new NIPT policy in Norway, the consequences can be startling. Finally, a lawsuit in the United States illustrates how an agency can risk forfeiting its legitimation in connection with the inaccuracy of NIPTs.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Education,Health (social science)
Reference52 articles.
1. Allyse, M., M. A. Minear, E. Berson, S. Sridhar, M. Rote, A. Hung, and S. Chandrasekharan. 2015. Non-invasive prenatal testing: a review of international implementation and challenges. International Journal of Women’s Health 2015: 7: 113–126.
2. Baldus, M. 2018. Verantwortete Elternschaft? Dilemmata des Elternwerdens im Kontext pränataler Diagnostik. Psychosozial, Jg. 41, Heft 1: 8–17.
3. Baldus, M. 2016. Dominanz des Marktes. Gen-ethischer Informationsdienst (GiD) 237: 111–113.
4. Baldus, M. 2006. Von der Diagnose zur Entscheidung. Eine Analyse von Entscheidungsprozessen für das Austragen der Schwangerschaft nach der pränatalen Diagnose Down-Syndrom. Bad Heilbrunn: Klinkhardt.
5. Barron’s, Newsfile. 2022. SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Natera, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2022 - (NTRA) https://www.barrons.com/articles/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-natera-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-june-27-2022-ntra-01655378179. Accessed 7 August 2022.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献